Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure

An observational study of Blood Pressure, run by AstraZeneca at 369 sites in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Trial summary

Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control. Read more about this study

Who is it for?: Ages 18 years and older
Conditions the study is for: Blood Pressure
How many people: 1,200 participants
Where: 369 sitesFrance
Study dates: Jun 2009to Dec 2009
Phase: Observational
Are there results?: None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

Ages 18 years and older
All sexes
No healthy volunteers
Adult, Older adult

Study population: First 2 consecutive adults with hypertension, without known cardio vascular or renal disease,seen by Cardiologists

Who may be able to join

Adults with hypertension (treated or not), without known cardiovascular or renal disease.

Who cannot join

None listed.

Trial locations and contacts

369 sites in 1 country.

City, postcode or hospital

300 sites in 1 country

France300 sites

Research Site
Abbeville
Research Site
Aire-sur-l'Adour
Research Site
Aix-en-Provence
Research Site
Ajaccio
Research Site
Albi
Research Site
Alençon
Research Site
Alès
Research Site
Ambérieu-en-Bugey
Research Site
Ambilly
Research Site
Amiens
Research Site
Andrézieux-Bouthéon
Research Site
Angers
Research Site
Angoulême
Research Site
Annecy
Research Site
Annemasse
Research Site
Antibes
Research Site
Antony
Research Site
Apt
Research Site
Arbois
Research Site
Arles
Research Site
Armentières
Research Site
Asnières-sur-Seine
Research Site
Aubenas
Research Site
Aubervilliers
Research Site
Auch
Research Site
Auchel
Research Site
Aulnay-sous-Bois
Research Site
Bagnères-de-Bigorre
Research Site
Bagnols-sur-Cèze
Research Site
Baie Mahault
Research Site
Bailleul
Research Site
Basse Terre
Research Site
Bastia
Research Site
Bayeux
Research Site
Beauchamp
Research Site
Beaumont
Research Site
Beaumont-de-Lomagne
Research Site
Beaumont-sur-Oise
Research Site
Beausoleil
Research Site
Beauvais
Research Site
Belfort
Research Site
Bellegarde-sur-Valserine
Research Site
Belley
Research Site
Bergerac
Research Site
Besançon
Research Site
Béthune
Research Site
Béziers
Research Site
Biscarrosse
Research Site
Blaye
Research Site
Bobigny
Research Site
Bois-Colombes
Research Site
Bois-Guillaume
Research Site
Bordeaux
Research Site
Boulogne-Billancourt
Research Site
Bourges
Research Site
Bourgoin
Research Site
Brest
Research Site
Brive-la-Gaillarde
Research Site
Bron
Research Site
Brunoy
Research Site
Bry-sur-Marne
Research Site
Bussy-Saint-Georges
Research Site
Caen
Research Site
Cagnes-sur-Mer
Research Site
Cahors
Research Site
Caluire-et-Cuire
Research Site
Cambo-les-Bains
Research Site
Carcassonne
Research Site
Carpentras
Research Site
Carquefou
Research Site
Castanet-Tolosan
Research Site
Castelnau-le-Lez
Research Site
Castelnaudary
Research Site
Castelsarrasin
Research Site
Castres
Research Site
Cenon
Research Site
Cergy
Research Site
Châlons-en-Champagne
Research Site
Chambéry
Research Site
Chamonix
Research Site
Champigny-sur-Marne
Research Site
Charleville-Mézières
Research Site
Chartres
Research Site
Château-d'Olonne
Research Site
Château-Thierry
Research Site
Châteaubernard
Research Site
Châteauroux
Research Site
Châtillon-sur-Seine
Research Site
Chatou
Research Site
Chelles
Research Site
Cherbourg Octeville
Research Site
Clermont-Ferrand
Research Site
Compiègne
Research Site
Condé-sur-l'Escaut
Research Site
Conflans Ste Honorine
Research Site
Coubron
Research Site
Courbevoie
Research Site
Coutances
Research Site
Creil
Research Site
Croix
Research Site
Dax
Research Site
Deauville
Research Site
Décines-Charpieu
Research Site
Denain
Research Site
Dieppe
Research Site
Dijon
Research Site
Dinard
Research Site
Divion
Research Site
Dole
Research Site
Domont
Research Site
Douai
Research Site
Draguignan
Research Site
Dunkirk
Research Site
Échirolles
Research Site
Elbeuf
Research Site
Enghien-les-Bains
Research Site
Épernay
Research Site
Épinal
Research Site
Esbly
Research Site
Étampes
Research Site
Évecquemont
Research Site
Évreux
Research Site
Faches-Thumesnil
Research Site
Firminy
Research Site
Floirac
Research Site
Fontaine
Research Site
Fontainebleau
Research Site
Fontenay-sous-Bois
Research Site
Fort de France
Research Site
Fougères
Research Site
Fourmies
Research Site
Frontignan
Research Site
Gagny
Research Site
Gap
Research Site
Garches
Research Site
Gasville-Oisème
Research Site
Genas
Research Site
Gennevilliers
Research Site
Gien
Research Site
Givet
Research Site
Givors
Research Site
Gleizé
Research Site
Gourdon
Research Site
Gray
Research Site
Grenoble
Research Site
Guebwiller
Research Site
Guéret
Research Site
Guilherand-Granges
Research Site
Hagondange
Research Site
Haguenau
Research Site
Héricourt
Research Site
Hérouville-Saint-Clair
Research Site
Hesdin
Research Site
Hyères
Research Site
Issy-les-Moulineaux
Research Site
Ivry-sur-Seine
Research Site
Jonzac
Research Site
Juan-les-Pins
Research Site
Juvisy-sur-Orge
Research Site
L'Isle-sur-la-Sorgue
Research Site
La Garenne-Colombes
Research Site
La Madeleine
Research Site
La Seyne-sur-Mer
Research Site
Lamotte-Beuvron
Research Site
Lanester
Research Site
Langon
Research Site
Lannemezan
Research Site
Lannion
Research Site
LArbresle
Research Site
Le Chesnay
Research Site
Le Havre
Research Site
Le Mans
Research Site
Le Perreux-sur-Marne
Research Site
Le Pontet
Research Site
Le Port
Research Site
Le Port-Marly
Research Site
Le Relecq-Kerhuon
Research Site
Le Tampon
Research Site
Lens
Research Site
Les Ulis
Research Site
Lesparre-Médoc
Research Site
Levallois-Perret
Research Site
Liévin
Research Site
Lille
Research Site
Limoges
Research Site
Limoux
Research Site
Lisieux
Research Site
Livry-Gargan
Research Site
Longjumeau
Research Site
Loos
Research Site
Lorient
Research Site
Lunel
Research Site
Lyon
Research Site
Mainvilliers
Research Site
Maisons-Alfort
Research Site
Marck En Baroeul
Research Site
Marmande
Research Site
Maromme
Research Site
Marseille
Research Site
Marvejols
Research Site
Massy
Research Site
Maubeuge
Research Site
Melun
Research Site
Mende
Research Site
Mennecy
Research Site
Mérignac
Research Site
Metz
Research Site
Millau
Research Site
Mont-de-Marsan
Research Site
Montargis
Research Site
Montauban
Research Site
Montbéliard
Research Site
Montbrison
Research Site
Montmorillon
Research Site
Montpellier
Research Site
Montreuil
Research Site
Montrouge
Research Site
Morlaix
Research Site
Nancy
Research Site
Nanterre
Research Site
Nantes
Research Site
Narbonne
Research Site
Neufchâteau
Research Site
Nevers
Research Site
Nice
Research Site
Nîmes
Research Site
Niort
Research Site
Noisy-le-Sec
Research Site
Noyon
Research Site
Oignies
Research Site
Olivet
Research Site
Ollioules
Research Site
Orléans
Research Site
Orly
Research Site
Orthez
Research Site
Pamiers
Research Site
Pantin
Research Site
Paray-le-Monial
Research Site
Paris
Research Site
Pau
Research Site
Péronne
Research Site
Perpignan
Research Site
Pierrelatte
Research Site
Pithiviers
Research Site
Plaisance-du-Touch
Research Site
Ploërmel
Research Site
Pointe à Pitre
Research Site
Poitiers
Research Site
Pompey
Research Site
Pont-à-Mousson
Research Site
Pont-d'Héry
Research Site
Pontarlier
Research Site
Pontault-Combault
Research Site
Pontcharra
Research Site
Pontoise
Research Site
Prades
Research Site
Prévessin-Moëns
Research Site
Puilboreau
Research Site
Quimperlé
Research Site
Quincy-sous-Sénart
Research Site
Rambouillet
Research Site
Reims
Research Site
Rennes
Research Site
Revel
Research Site
Rillieux-la-Pape
Research Site
Rixheim
Research Site
Rodez
Research Site
Romans-sur-Isère
Research Site
Romorantin-Lanthenay
Research Site
Rosny-sous-Bois
Research Site
Roubaix
Research Site
Rouen
Research Site
Royan
Research Site
Royat
Research Site
Sablé-sur-Sarthe
Research Site
Saint-Amand-Montrond
Research Site
Saint-André-les-Vergers
Research Site
Saint-Avold
Research Site
Saint-Brieuc
Research Site
Saint-Chamond
Research Site
Saint-Dié
Research Site
Saint-Etienne
Research Site
Saint-Flour
Research Site
Saint-Germain-en-Laye
Research Site
Saint-Herblain
Research Site
Saint-Ismier
Research Site
Saint-Jean-de-Luz
Research Site
Saint-Laurent-du-Var
Research Site
Saint-Leu
Research Site
Saint-Louis
Research Site
Saint-Martin-Boulogne
Research Site
Saint-Martin-d'Aubigny
Research Site
Saint-Martin-d'Hères
Research Site
Saint-Nazaire
Research Site
Saint-Orens-de-Gameville
Research Site
Saint-Paul-lès-Dax
Research Site
Saint-Pierre-des-Corps
Research Site
Saint-Pol-de-Léon
Research Site
Saint-Pol-sur-Mer
Research Site
Saint-Quentin

Other trials in France

About this study

Official title: Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure Without Known Cardio Vascular or Renal Disease, Stratified on Blood Pressure Control.

Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.

Conditions: Blood Pressure
Keywords: Target organs impairment, High blood pressure, Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
Medical subject headings: Hypertension, Kidney Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

Study groups in NCT00925470
Study group	Role	What they receive
1		Not described

What is being measured

The primary outcome is the main question the study is designed to answer.

To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)
Measured: Once

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

Jun 2009Dec 2009

First posted22 Jun 2009 (estimated)
Study startJun 2009
Study completionDec 2009

Resources

Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
Other trials for Blood PressureStudies of the same condition, open and under way.
More trials run by AstraZenecaThe sponsor's other registered studies.
What the trial phases meanHow a treatment moves from first tests in people to approval.

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design

Study type: Observational
Observational model: Cohort
Time perspective: Cross-sectional
Enrolment: 1,200 participants (estimated)

IDs, dates and publications

ClinicalTrials.gov ID: NCT00925470
Sponsor's protocol ID: NIS-CFR-DUM-2009/1
Acronym: PREVENTA
Status last verified: Dec 2009
First submitted: 19 Jun 2009
Last updated: 18 Dec 2009
Results posted: No
Data monitoring committee: No

Want to know more?

The sponsor has not listed a contact. The official record may have more details.

Talk to your doctor first and take this page with you. Only the study team can confirm whether you can join.

Questions to ask the study team

What is the study trying to find out?
What would I need to do, and how often would I visit?
Could I receive a placebo instead of the treatment?
What are the possible risks and benefits for me?
Will it cost me anything? Are travel or time paid for?
Can I keep seeing my own doctor during the study?
What happens when the study ends?

See locations

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingPhase 4
Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions
Hematologic Test, Agranulocytosis
Not yet recruiting
Acute Effects of Mat Pilates on Blood Pressure Response to Mental Stress in Higher Education Teachers
Behavior

All Blood Pressure trials

Study at a glance

From the registry record, last updated by the sponsor on 18 Dec 2009. Recruitment status is as the sponsor reported it: confirm with the study team.

Official title: Evaluation of Target Organs Impairment on Patients Suffering From High Blood Pressure Without Known Cardio Vascular or Renal Disease, Stratified on Blood Pressure Control.
ClinicalTrials.gov ID: NCT00925470
Acronym / sponsor ID: PREVENTA / NIS-CFR-DUM-2009/1
Conditions: Blood Pressure
Keywords: Target organs impairment, High blood pressure, Evaluation of target organs impairment on patients suffering from high blood pressure without known cardiovascular or renal disease
Study type: Observational
Recruitment status: Completed
Enrolment: 1,200 participants (estimated)
Lead sponsor: AstraZenecaIndustry (pharma, biotech, devices)
Study start: Jun 2009
Study completion: Dec 2009 (actual)
First posted: 22 Jun 2009 (estimated)
Results: Not posted in the source record

Clinical summary

The research question as the sponsor registered it. This describes what the study plans to test, not what it found.

Evaluation of target organs impairment on patients suffering from high blood pressure without known cardio vascular or renal disease, stratified on blood pressure control.

Study design

Observational model: Cohort
Time perspective: Cross-sectional
Number of arms: 1

Arm	Type	Receives
1	–	–

Who may qualify

Ages: 18 years and older
Sex: All
Healthy volunteers: Not accepted
Age groups: Adult, Older adult
Study population: First 2 consecutive adults with hypertension, without known cardio vascular or renal disease,seen by Cardiologists

Key inclusion criteria (1 listed)

Adults with hypertension (treated or not), without known cardiovascular or renal disease.

Key exclusion criteria (0 listed)

Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.

Primary outcome

To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not)
Time frame: Once

Results and safety

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

Research links

Official record on ClinicalTrials.govLast updated by the sponsor 18 Dec 2009.

Related trials for Blood Pressure

Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
Chronic Kidney Disease and Hypertension
Recruiting
Guiding Optimal Blood Pressure Management in Peritoneal Dialysis Pilot Trial
End Stage Kidney Disease (ESKD), Hypertension (HTN)
RecruitingPhase 4
Hematological Safety of Dipyrone Versus Paracetamol After Dental Extractions
Hematologic Test, Agranulocytosis
Not yet recruiting
Acute Effects of Mat Pilates on Blood Pressure Response to Mental Stress in Higher Education Teachers
Behavior

Referral and contact

AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.

Alain Castaigne, Medical Director study director

AstraZeneca

369 sites in 1 country: see every site and its status.

Questions about this trial

What is this clinical trial studying?

An observational study of Blood Pressure, run by AstraZeneca at 369 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 0 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 18 Dec 2009. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 369 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

To evaluate the frequency of evaluation of target organs preclinical impairment on patients without known cardiovascular or renal disease, taking into consideration the blood pressure level (controlled HBP or not) (time frame: Once). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00925470.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Dec 2009.